"Guanosine Triphosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety.
Descriptor ID |
D006160
|
MeSH Number(s) |
D03.633.100.759.646.454.504 D13.695.667.454.504 D13.695.827.426.504
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Guanosine Triphosphate".
Below are MeSH descriptors whose meaning is more specific than "Guanosine Triphosphate".
This graph shows the total number of publications written about "Guanosine Triphosphate" by people in this website by year, and whether "Guanosine Triphosphate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 3 | 5 |
1996 | 1 | 3 | 4 |
1997 | 1 | 3 | 4 |
1998 | 0 | 7 | 7 |
1999 | 0 | 1 | 1 |
2000 | 3 | 3 | 6 |
2001 | 0 | 2 | 2 |
2002 | 0 | 2 | 2 |
2003 | 1 | 3 | 4 |
2005 | 1 | 0 | 1 |
2008 | 0 | 2 | 2 |
2009 | 1 | 0 | 1 |
2011 | 0 | 2 | 2 |
2012 | 1 | 2 | 3 |
2015 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
2018 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2022 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Guanosine Triphosphate" by people in Profiles.
-
Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket. Cell. 2024 Oct 31; 187(22):6379-6392.e17.
-
Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation. Cancer Lett. 2024 Apr 01; 586:216694.
-
GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress. Cancer Discov. 2024 01 12; 14(1):158-175.
-
Mitochondrial GTP metabolism controls reproductive aging in C.?elegans. Dev Cell. 2023 Dec 04; 58(23):2718-2731.e7.
-
Drugging KRAS: current perspectives and state-of-art review. J Hematol Oncol. 2022 10 25; 15(1):152.
-
Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation. J Clin Immunol. 2022 08; 42(6):1280-1292.
-
Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer. J Clin Invest. 2021 01 04; 131(1).
-
Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach. J Biomol Struct Dyn. 2022 03; 40(4):1571-1585.
-
Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset. Nat Commun. 2019 10 29; 10(1):4914.
-
Let K-Ras activate its own inhibitor. Nat Struct Mol Biol. 2018 06; 25(6):435-437.